Aerie Pharmaceuticals Inc. diskutieren
Aerie Pharmaceuticals Inc.
WKN: A1W7RL / Symbol: AERI / Name: Aerie Pharma / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
14,80 €
-
(Laufzeit überschritten)
(Laufzeit überschritten)
(Laufzeit überschritten)
SecteurRecherche biotechnologique et médicale Agenda 19/09 | 17:55 Présentation
Manufactures pharmaceutical products
Aerie Pharmaceuticals, Inc. is a clinical stage pharmaceutical company, which engages in the discovery, development, and commercialization of therapies for the treatment of patients with glaucoma and diseases of the eye. Its products include Rhopressa and Roclatan.
The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on June 22, 2005 and is headquartered in Durham, NC.
Aerie Pharmaceuticals, Inc. is a clinical stage pharmaceutical company, which engages in the discovery, development, and commercialization of therapies for the treatment of patients with glaucoma and diseases of the eye. Its products include Rhopressa and Roclatan.
The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on June 22, 2005 and is headquartered in Durham, NC.
Nombre d'employés : 160 personnes.
(Zielkurs erreicht)
stratec stimmt dem Sentiment von 'Buy' zu
JMP Securities likes Aerie Pharmaceuticals (AERI) today as they reiterate their Buy rating and $80 price target. JMP's analyst believes Q3 revenue will hit $5.4 million, above the $4.8 million consensus. He also believes 'revenue and prescriptions to accelerate in 2019 when Aerie obtains extended Medicare Part D formulary coverage and Roclatan is approved'
Geht's
wieder hoch?
(Vom Mitglied beendet)
Wiedereinstieg
nach Stoploss.
(Vom Mitglied beendet)
klostergang stimmt dem Crowdsentiment von 'Buy' zu
klostergang stimmt am 21.02.2019 dem Buy-Crowdsentiment mit dem Kursziel 64$ zu.
(Vom Mitglied beendet)
(Stop Loss Kurs erreicht)
(Vom Mitglied beendet)
(Laufzeit überschritten)
Sell mit Kursziel 13,0
Kursziel geändert auf 11,0
Neueste Beiträge
robertinio in Stelco Inc. diskutieren